Related Experiment Videos
Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2
Paula A Clark1, Susana Llanos, Gordon Peters
1Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, 61 Lincoln's Inn Fields, UK.
Abstract:
The small basic protein p14ARF, encoded by one of the alternative transcripts from the human INK4A/ARF locus, interferes with MDM2-mediated ubiquitination of the p53 tumour suppressor protein. The resultant stabilization of p53 leads to increased expression of p53-regulated genes, such as MDM2 itself and the cyclin-dependent kinase inhibitor p21(CIP1). Here we relate physical interactions between p14ARF and MDM2, as determined using synthetic peptides and systematic deletions of p14ARF, with consequential effects on p53 stabilization and transcriptional activity. The data imply that the amino terminal half of p14ARF, encoded by the alternative first exon (exon 1beta) contacts MDM2 through multiple domains that can independently impede MDM2-mediated degradation of p53, provided that they are localized in the cell nucleus. As well as identifying previously unrecognized functional domains, our findings offer an explanation for the relative paucity of missense mutations in exon 1beta in human tumours.
Insights
The p14ARF protein stabilizes the p53 tumor suppressor by interacting with MDM2. This interaction, mediated by p14ARF's amino-terminal region, impedes p53 degradation and enhances its tumor-suppressing activity.
Area of Science:
- Molecular Biology
- Cancer Biology
- Protein Interactions
Background:
- The INK4A/ARF locus encodes p14ARF, a protein that regulates the p53 tumor suppressor.
- p53 is a critical protein for preventing tumor formation, and its stability is tightly controlled.
- MDM2 is a key E3 ubiquitin ligase that targets p53 for degradation.
Purpose of the Study:
- To investigate the physical interactions between p14ARF and MDM2.
- To determine how these interactions affect p53 stabilization and transcriptional activity.
- To identify functional domains within p14ARF responsible for MDM2 interaction and p53 regulation.
Main Methods:
- Utilized synthetic peptides to study p14ARF-MDM2 interactions.
- Employed systematic deletion analysis of p14ARF to map functional domains.
- Assessed p53 stabilization and transcriptional activity in response to p14ARF and MDM2 interactions.
Main Results:
- The amino-terminal half of p14ARF, encoded by exon 1beta, directly contacts MDM2.
- Multiple domains within the amino-terminal region of p14ARF can independently inhibit MDM2-mediated p53 degradation.
- These inhibitory effects are dependent on the localization of p14ARF within the cell nucleus.
- Identified previously unrecognized functional domains in p14ARF's exon 1beta.
Conclusions:
- p14ARF interacts with MDM2 through multiple domains in its amino-terminal region, leading to p53 stabilization.
- These findings provide a molecular explanation for the scarcity of missense mutations in exon 1beta of the INK4A/ARF locus in human tumors.
- The study elucidates a key mechanism of p53 regulation by p14ARF, relevant to cancer biology.